<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-11-15</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543700/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">An additional gastrojejunostomy may reduce the incidence of moderate and severe delayed gastric emptying after distal segmental duodenectomy for gastrointestinal stromal tumors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543700-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The addition of gastrojejunostomy and Braun&rsquo;s jejunojejunostomy in distal segmental duodenectomy can reduce the incidence of grade B-C DGE, potentially facilitating timely adjuvant imatinib therapy. Future multicenter studies are needed to confirm these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543701/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Late-onset drug-resistant epilepsy in pyridoxamine 5&#39;-phosphate oxidase deficiency: a case report</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543701-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Physicians ought to be aware of manifestations of vitamin B6 deficiency such as mimicking tic and consider it in the differential for drug-resistant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543763/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543763-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: The risk of breast cancer patients for long-term side effects of therapy such as neurotoxicity and cardiotoxicity as well as late effects regarding comorbidities varies from individual to individual. Personalised follow-up care concepts that are tailored to individual needs and the risk of recurrences, side effects and late effects are lacking in routine care in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543778/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Cardiac arrhythmias during and after thoracic irradiation for malignancies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543778-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Thoracic radiotherapy can be safely administered in patients with CIEDs. However, patients with a history of arrhythmia are more prone to arrhythmic events during and after radiation. These findings highlight the need for personalized arrhythmia management strategies and further research to understand the mechanisms underlying the antiarrhythmic effects of thoracic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543799/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Optical control of cardiac electrophysiology by the photochromic ligand azobupivacaine 2</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543799-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION AND IMPLICATIONS: The present study provides the first proof of concept that AB2 enables gradual control of cardiac electrophysiology by light. AB2 may hence open the door to the development of an optical defibrillator based on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543914/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Predictors for improvement in personality functioning during outpatient psychotherapy: A machine learning approach within a psychodynamic psychotherapy sample</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543914-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Overall, the improvement in personality functioning during psychotherapy is determined more by the sum of a large number of small effects than by individual variables. In particular, variables that capture social areas of life proved to be robust &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39543950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">The prognostic value of cystography-measured bladder capacity on very early continence rates after radical prostatectomy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39543950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The cystography-measured bladder capacity may be a good predictor of the recovery of post-prostatectomy urinary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544316/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Microvascular Reconstructions in Elderly Patients With Oral Squamous Cell Carcinoma - Too Old for Surgical Treatment?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544316-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Tumor surgery including neck dissection in combination with primary microvascular reconstruction is a safe therapy in patients of advanced age. This results in excellent oncological outcome with no significant disadvantages in terms of perioperative morbidity, hospitalization or flap &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544372/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Implementing a stabilizing intervention for traumatized refugees in temporary accommodations in South-West Germany - a randomized controlled pilot trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544372-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The prevalence of trauma-related disorders, such as post-traumatic stress disorder (PTSD), as well as depressive or anxiety disorders, are significantly increased in refugees compared to the general population. This is due to the high risk of burdening and potentially traumatic experiences before, during and after their flight. However, the treatment options for these mental illnesses are significantly limited due to the legal uncertainties surrounding the asylum procedure as well as &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544530/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Presolar Grains as Probes of Supernova Nucleosynthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544530-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We provide an overview of the isotopic signatures of presolar supernova grains, specifically focusing on ^(44)Ti-containing grains with robustly inferred supernova origins and their implications for nucleosynthesis and mixing mechanisms in supernovae. Recent technique advancements have enabled the differentiation between radiogenic (from ^(44)Ti decay) and nonradiogenic ^(44)Ca excesses in presolar grains, made possible by enhanced spatial resolution of Ca-Ti isotope analyses with the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544625/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Understanding the Risk Factors, Burden, and Interventions for Chronic Respiratory Diseases in Low- and Middle-Income Countries: A Scoping Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544625-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our research shows a strong link between air pollution, occupational and environmental exposures, and the prevalence of COPD and asthma in LMICs. It suggests that targeted interventions are effective ways to mitigate these diseases and also highlights the significant impact of climate change on respiratory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544885/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Sputum availability and quality in country-level TB prevalence surveys</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544885-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544941/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544941-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: We report the partial regression of metastatic squamous cell carcinoma (SCC) after reduction of long-term azathioprine therapy while awaiting surgery. The patient was a 69-year-old man with a history of kidney transplantation. Moderately differentiated SCC arising in the anterior neck was initially diagnosed, followed later by poorly differentiated SCC metastases to cervical lymph nodes. Lymph node clearance was performed 28 days after a reduction in azathioprine dosage. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39544950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&amp;fc=20220919201732&amp;ff=20241115175759&amp;v=2.18.0.post9&#43;e462414">Pneumonia in Transplant Recipients: A Comprehensive Review of Diagnosis and Management</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39544950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1juknaekwk5-jhnlosyrqeevu-lgfd382ao3uol7pziqjjxyzk-fc-20220919201732-ff-20241115175759-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Transplant recipients have an increased risk of complications, including graft dysfunction and infections, which can be life-threatening if not recognized early. Pneumonia ranks as one of the most frequent complications in both solid organ and hematopoietic stem cell transplants. Clinical symptoms manifest late during infections in immunocompromised patients. An aggressive approach centered on early confirmatory diagnosis and a low threshold for empiric therapy is often the most &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545335/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Desmoid tumors: Old and new drugs for a rare and challenging disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545335-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545345/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Long-Term Single-Molecule Tracking in Living Cells Using Weak-Affinity Protein Labeling</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545345-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Single-particle tracking (SPT) has become a powerful tool to monitor the dynamics of membrane proteins in living cells. However, permanent labeling strategies for SPT suffer from photobleaching as a major limitation, restricting observation times, and obstructing the study of long-term cellular processes within single living cells. Here, we use exchangeable HaloTag Ligands (xHTLs) as an easy-to-apply labeling approach for live-cell SPT and demonstrate extended observation times of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545505/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Haematogenous seeding in mycosis fungoides and Sézary syndrome: Current evidence and clinical implications</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545505-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of diseases characterised by abnormal neoplastic T-cell growth in the skin. Mycosis fungoides (MF), the most common CTCL, manifests as erythematous skin patches and/or plaques, tumours or erythroderma. The disease may involve blood, lymph nodes and rarely viscera. Sézary syndrome (SS) is a unique leukaemia/lymphoma syndrome related to MF, which presents with blood and skin involvement at diagnosis. The pathogenesis of MF/SS is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545514/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Pain Remission Following Delayed Targeted Muscle Reinnervation in Amputees</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545514-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Targeted muscle reinnervation (TMR) has demonstrated efficacy for treatment of neuropathic pain. This study aims to identify patients for whom delayed TMR may be most effective and to identify associated factors for favorable pain outcomes in this patient &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545524/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Gliosarcoma: A Multi-Institutional Analysis on Clinical Outcomes and Prognostic Factors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545524-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Trimodal therapy comprising surgical resection, pRT and TMZ-based chemotherapy appears to have the most beneficial effect on survival in GSM patients. Smaller tumor size, younger age and methylated MGMT promoters are associated with improved survival. To our knowledge, this is the largest multi-institutional cohort study investigating outcomes and prognostic factors for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545723/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">T-shaped 14 Electron Rhodium Complexes: Potential Active Species in C-H Activation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545723-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Two T-shaped 14-electron rhodium complexes 2a and 2b, &ldquo;framed&rdquo; and thus stabilized by PNP pincer ligands have been synthesized. The bis(t-butyl)phosphine derived PNPtBu-rhodium 2a was isolated from pentane as the more stable cyclometalated Rh(III) hydrido complex and found to be in equilibrium with the T-shaped 14e-Rh(I) complex 2aT which itself could be directly crystallized upon change of the solvent. The cyclometallation is suppressed using an adamantyl substituted PNPAd ligand to give &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39545955/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241115181609&amp;v=2.18.0.post9&#43;e462414">Fine-tuning stress responses by auxiliary feedback loops that sense damage repair</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39545955-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241115181609-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mogk and den Brave discuss exciting results from a comprehensive screen of heat shock response components in yeast, published in this issue by Pincus and colleagues (<a href="https://doi.org/10.1083/jcb.202401082)">https://doi.org/10.1083/jcb.202401082)</a>. Their work reveals modulatory regulatory loops that fine-tune the timing of the shutdown of this highly conserved &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0nhu0WFh">Trump不能不经过国会参议院直接任命内阁成员。他可以强制国会recess（休会），然后任命内阁，但这样不仅操作难度大，且会被告上法庭，更重要的是，他只能任命临...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0nhu0wfh/">
    
    
    
    
    
      
    
    Trump不能不经过国会参议院直接任命内阁成员。他可以强制国会recess（休会），然后任命内阁，但这样不仅操作难度大，且会被告上法庭，更重要的是，他只能任命临时内阁成员，一旦国会恢复，那么要重新恢复任命过程。如果还记得他2017-2021年第一任操作，他最终选择的方式是acting，就是各个部委，都是代理部长。第二是他既不能废除在美国出生后自动赋予的美国公民权，也不能任第三次总统。许多人不理解美国的立法和法庭判决。出生公民权是美国宪法第14修正案，一个人最多只能任两届总统（不管连续还是不连续）是美国宪法第22修正案。立法需要众议院简单多数和参议院60%通过。但是修改上述宪法，需要众议院和参议院都2/3通过才能获得提议（Proposal），最终 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0onYxTCk">很多人说美国内政本质上是个数学游戏，因为内政其实就是在数票数。对美国内政真有兴趣的人，会知道美国内政主要是通过国会立法实现的，而联邦法院系统（尤其是最...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0onyxtck/">
    
    
    
    
    
      
    
    很多人说美国内政本质上是个数学游戏，因为内政其实就是在数票数。对美国内政真有兴趣的人，会知道美国内政主要是通过国会立法实现的，而联邦法院系统（尤其是最高法）有对很多政策的释法权（认同或否决）。所以美国内政和程序，很多都是通过国会和法官投票决定的，比如任命内阁和法官需要参议院51票，通过立法和财政预算需要众议院简单多数和参议院60票以上，弹劾总统则需要众议院简单多数和参议院67票，修宪则是天花板极难度。法庭也是如此，联邦上诉法庭（appeal court）一般3个法官2个多数可以判决，而最高法9个法官简单多数（5个）可以判决。由此说美国内政是个数学游戏 - 就看你有没有足够票数。每个议员一般都有自己的纲领（个人网站上一般都可以找到）和投票纪录，对于一个关键 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0phWvHgA">拉丁裔是2024年大选投票变化最显著的一个选民群体，而他们投票变化的原因是过去一周很多媒体争相报道的焦点。今天538 podcast请了Carlos Odio做了一期节目，专门...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0phwvhga/">
    
    
    
    
    
      
    
    拉丁裔是2024年大选投票变化最显著的一个选民群体，而他们投票变化的原因是过去一周很多媒体争相报道的焦点。今天538 podcast请了Carlos Odio做了一期节目，专门分析了这次显著影响大选结果的拉丁裔的民意变化。Odio不仅是全美国最好的拉丁裔民意研究专家和pollster（民意调查专家）之一；他本人作为拉丁裔男性，十分关心和理解自己社区的民意变化。他今天说的几点非常有启发性。<!-- raw HTML omitted --><!-- raw HTML omitted -->四年前，Odio在538上介绍了2020年大选前拉丁裔民意变化，实际上在2020年大选前，拉丁裔就发生了显著的向美国保守派的变迁，而其中关键原因是他们获得信息的来源（<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/P0oJTkZse">说起来……微博玩了这么多年，我好像一次奖都没中过 - 转发 @52TOYS:&amp;ensp;由上影元文化正版授权，52TOYS联名上美影作品《天书奇谭》，用可动玩具再现经典！[憧...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-p0ojtkzse/">
    
    
    
    
    
      
    
    说起来……微博玩了这么多年，我好像一次奖都没中过<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@52TOYS<!-- raw HTML omitted -->: 由上影元文化正版授权，52TOYS联名上美影作品《天书奇谭》，用可动玩具再现经典！<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->发条、机关、关节可动……一套盲盒多重玩法！诙谐有趣，一玩一个上瘾~<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/P0p8VDzaH">早上出门前，电话响了。我手里正忙，喊马小烦帮忙开免提。他一开，那边传来亲切的问候：“家长你好，这里是海淀名师……” 他还没等我发话，“啪”就给挂了，然...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-p0p8vdzah/">
    
    
    
    
    
      
    
    早上出门前，电话响了。我手里正忙，喊马小烦帮忙开免提。他一开，那边传来亲切的问候：“家长你好，这里是海淀名师……” 他还没等我发话，“啪”就给挂了，然后转过头，用一种故作平静的微妙语气讲：“垃圾电话，不用理。”  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tAilFuv">陶陶居 - 转发 @水獭一般编-阿怡:&amp;ensp;广州老广们推荐个自己觉得可以的早茶呗</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tailfuv/">
    
    
    
    
    
      
    
    陶陶居<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@水獭一般编-阿怡<!-- raw HTML omitted -->: 广州老广们推荐个自己觉得可以的早茶呗 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tCiaqPY">🔻我们现在都是用三小时对接方案了，真快啊。🔻图4 via @Seger_YU #天舟八号发射# [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tciaqpy/">
    
    
    
    
    
      
    
    🔻我们现在都是用三小时对接方案了，真快啊。<!-- raw HTML omitted -->🔻图4 via <!-- raw HTML omitted -->@Seger_YU<!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#天舟八号发射#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hvneri51btj20zk0k0jrl.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbly1hvneri51btj20zk0k0jrl.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tFhadPu">丢[哆啦A梦害怕]//@徐家独子:慎入 评论配图 //@包容万物恒河水:陶陶居 - 转发 @水獭一般编-阿怡:&amp;ensp;广州老广们推荐个自己觉得可以的早茶呗</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tfhadpu/">
    
    
    
    
    
      
    
    丢<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@徐家独子<!-- raw HTML omitted -->:慎入 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/01/21/20/timeline_card_small_photo_default.png%22">https://h5.sinaimg.cn/upload/2015/01/21/20/timeline_card_small_photo_default.png&quot;</a> referrerpolicy=&ldquo;no-referrer&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tg6cSZi">🔻我花了好几秒钟才认出视频1这可怕的水下生物是什么……🔻via Nature is Amazing [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tg6cszi/">
    
    
    
    
    
      
    
    🔻我花了好几秒钟才认出视频1这可怕的水下生物是什么……<!-- raw HTML omitted -->🔻via Nature is Amazing <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tiri2Rs">🔻网友分享，一个测试视频。🔻俄乌冲突中，俄乌双方都曾尝试过无人机搭载轻武器，但是最终并没有普及。🔻可能是因为点杀伤不如面杀伤消费比高，并且技术所...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tiri2rs/">
    
    
    
    
    
      
    
    🔻网友分享，一个测试视频。<!-- raw HTML omitted -->🔻俄乌冲突中，俄乌双方都曾尝试过无人机搭载轻武器，但是最终并没有普及。<!-- raw HTML omitted -->🔻可能是因为点杀伤不如面杀伤消费比高，并且技术所限，在精准射击和效费比之间很难找到平衡。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax1.sinaimg.c">https://tvax1.sinaimg.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tm3fVQw">一个词点题：“释经权”。“没有经过小圈子点头认可转发吹捧，没有给小圈子里的老前辈们奉茶上供，你怎么好意思带着这么巨大的流量杀进我们的赛道里来呢？”//@2...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tm3fvqw/">
    
    
    
    
    
      
    
    一个词点题：“释经权”。“没有经过小圈子点头认可转发吹捧，没有给小圈子里的老前辈们奉茶上供，你怎么好意思带着这么巨大的流量杀进我们的赛道里来呢？”//<!-- raw HTML omitted -->@2点5次元的老破<!-- raw HTML omitted -->:最让我无语的是首页一些看起来岁月静好钻研传统文化的这种时候突然跳出来说些怪话…什么真的专心传承的手艺人没人看啦漂亮小姑娘搞点滤镜就一堆人追捧啦…什么你们不是喜欢农村氛围和传统文化你们就是喜欢她火啦……不管出发点是什么，这种做派真的还挺让人不适的<!-- raw HTML omitted -->&lt;img alt=&quot;[生病]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_shengbing-b740fa9852.png%22">https://h5.sinaimg.cn/m/emoticon/icon/default/d_shengbing-b740fa9852.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tmMA9uM">🔻有人说张玉宁进世界杯的几率现在比哈兰德大。🔻……别奶。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tmma9um/">
    
    
    
    
    
      
    
    🔻有人说张玉宁进世界杯的几率现在比哈兰德大。<!-- raw HTML omitted -->🔻……别奶。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0to44wcE">🔻仔细想想，美国候任总统第一时间能找到来海湖庄园一起站台的，居然是阿根廷。🔻这可比上一个任期的shinzo差远了。🔻真是一届不如一届。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0to44wce/">
    
    
    
    
    
      
    
    🔻仔细想想，美国候任总统第一时间能找到来海湖庄园一起站台的，居然是阿根廷。<!-- raw HTML omitted -->🔻这可比上一个任期的shinzo差远了。<!-- raw HTML omitted -->🔻真是一届不如一届。 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tqg3qKi">6 - 转发 @大大大餅干丶:&amp;ensp;台湾很多工厂都没有订单了...以前给台湾的订单太多，让绿色赚多了会搞台独，现在大陆给的订单也少了～台湾网友说他们工厂往年年底...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tqg3qki/">
    
    
    
    
    
      
    
    6<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@大大大餅干丶<!-- raw HTML omitted -->: 台湾很多工厂都没有订单了&hellip;<!-- raw HTML omitted --><!-- raw HTML omitted -->以前给台湾的订单太多，让绿色赚多了会搞台独，现在大陆给的订单也少了～<!-- raw HTML omitted --><!-- raw HTML omitted -->台湾网友说他们工厂往年年底时候很忙，但今年赖清德上台后闲得发慌，而回想起马英九时代，大家都赚翻了～<!-- raw HTML omitted --><!-- raw HTML omitted -->预测再过几年台湾很多工厂可能要倒闭或者移到外国，到时候大陆不用打台湾自己就想统一&hellip;<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaim">https://tvax2.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/P0tz7ALTA">你这是什么史观？其实就是强调清朝征服属性的史观，直接否定了中国近代以来形成的“少数民族必将被中华文明同化”的历史叙述方式。这就是小鬼子的内亚史观，通过...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-p0tz7alta/">
    
    
    
    
    
      
    
    你这是什么史观？其实就是强调清朝征服属性的史观，直接否定了中国近代以来形成的“少数民族必将被中华文明同化”的历史叙述方式。这就是小鬼子的内亚史观，通过这种反动理论，把中国几千年来各民族融合所形成的民系关系强行割裂，把现代中国各民族所建立的共同历史想象基础的华夏中心论去除，分化瓦解否定现代中国的一切。抱歉，跟日本学历史的帐号在我这里没有立足之地。//<!-- raw HTML omitted -->@天林晚钟<!-- raw HTML omitted -->:包包，推满文，断中华文脉，中国几乎成了文盲大国，这比乱编明史，否定历史更多。不能因为阿嫲被qj生子，所以后代就应该感谢那个qj犯吧，哪怕qj犯把这个原本富裕的家折腾得一贫如洗，虐待酷刑折磨家庭成员，可他毕竟是父亲啊！这种自虐史观恕我接受不能。<!-- raw HTML omitted -->&lt;img alt=&quot;[挖鼻]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/default/d_wabishi-816c">https://h5.sinaimg.cn/m/emoticon/icon/default/d_wabishi-816c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0nL3fTIB">久保史绪里 「被未来的我暴击！」EP.22 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0nl3ftib/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->「被未来的我暴击！」EP.22 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/0">https://h5.sinaimg.cn/upload/2015/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0nNKtBco">久保史绪里 乃木坂46 37th 「步道橋」Type-D 封面 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0nnktbco/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->乃木坂46 37th 「步道橋」Type-D 封面 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0qE04aCp">久保史绪里#久保史绪里手机博# 2024.11.15 18:10「哟」今天也辛苦了昨天也久违地一回家就睡着了、、、、虽然也有这样的日子，但精精神神地出发吧！！！今天也要...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0qe04acp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;is">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;is</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0tiho4v7">久保史绪里#shiorigram# 第六周一次过重播谢谢啦太棒了...集中精神实时看了。 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-15</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0tiho4v7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39539235/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">A Low-Cost Workflow to Generate Virtual and Physical Three-Dimensional Models of Cardiac Structures</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39539235-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Three-dimensional modeling and printing might improve planning and safety of congenital cardiac surgical treatment. Furthermore, it is a useful tool for education of parents and medical professionals. This workflow increases its suitability for routine use also in regions with low economic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39539954/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">CardioMEA: comprehensive data analysis platform for studying cardiac diseases and drug responses</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39539954-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: In recent years, high-density microelectrode arrays (HD-MEAs) have emerged as a valuable tool in preclinical research for characterizing the electrophysiology of human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs). HD-MEAs enable the capturing of both extracellular and intracellular signals on a large scale, while minimizing potential damage to the cell. However, despite technological advancements of HD-MEAs, there is a lack of effective data-analysis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39540283/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">Emerging Imaging Techniques for Atherosclerosis in Systemic Immune-Mediated Inflammatory Conditions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39540283-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Atherosclerosis affects patients with systemic immune-mediated inflammatory diseases at an increased rate compared with the general population. In recent years, our understanding of the pathophysiology of atherosclerosis has advanced considerably. Nevertheless, cardiovascular imaging modalities that can adequately assess the biological background of atherosclerosis have not reached widespread clinical adoption. Novel developments in cardiac imaging have the potential to enhance the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39540861/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">Evaluating the Impact of Retinal Vessel Segmentation Metrics on Retest Reliability in a Clinical Setting: A Comparative Analysis Using AutoMorph</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39540861-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our findings highlight a considerable volatility in the reliability of some retinal biomarkers. Improving retest could allow disease progression modeling in smaller datasets or an individualized treatment approach. Image quality is moderately predictive of retest reliability, and further work is warranted to understand the reasons behind our observations better and thus ensure consistent retest &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39540917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241114180137&amp;v=2.18.0.post9&#43;e462414">Psychological Women&#39;s Liberation: Feminist Therapy Between Psychology and the Women&#39;s Movement in the Federal Republic of Germany in the 1970s</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39540917-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241114180137-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    From the late 1960s onwards, the early second women&rsquo;s movement encompassed all areas of West German society. This included debates about how women&rsquo;s healthcare could be improved in a self-determined, women-friendly way and in line with feminist ideals. These debates were also held with regard to the general boom in psychotherapy at the time. This article explores the question of how debates around feminist therapy emerged in the Federal Republic of Germany. It also looks at the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541094/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241114180133&amp;v=2.18.0.post9&#43;e462414">Inebilizumab for Treatment of IgG4-Related Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541094-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241114180133-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Inebilizumab reduced the risk of flares of IgG4-related disease and increased the likelihood of flare-free complete remission at 1 year, confirming the role of CD19-targeted B-cell depletion as a potential treatment for IgG4-related disease. (Funded by Amgen; MITIGATE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541094/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Inebilizumab for Treatment of IgG4-Related Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541094-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241115181608-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Inebilizumab reduced the risk of flares of IgG4-related disease and increased the likelihood of flare-free complete remission at 1 year, confirming the role of CD19-targeted B-cell depletion as a potential treatment for IgG4-related disease. (Funded by Amgen; MITIGATE ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Let&#39;s YAP about ITP</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541102-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541102/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Let&#39;s YAP about ITP</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541102-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541103/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Location, location, location: EMD in MM</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541103-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541103/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Location, location, location: EMD in MM</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541103-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541104/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Oxidative hemolysis due to phenazopyridine in the absence of G6PD deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541104-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541104/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Oxidative hemolysis due to phenazopyridine in the absence of G6PD deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541104-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541105/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241114180132&amp;v=2.18.0.post9&#43;e462414">Ruxolitinib REACHes FOR children with GVHD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541105-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241114180132-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541105/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Ruxolitinib REACHes FOR children with GVHD</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541105-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541189/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241115181459&amp;v=2.18.0.post9&#43;e462414">SpaGIC: graph-informed clustering in spatial transcriptomics via self-supervised contrastive learning</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541189-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241115181459-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spatial transcriptomics technologies enable the generation of gene expression profiles while preserving spatial context, providing the potential for in-depth understanding of spatial-specific tissue heterogeneity. Leveraging gene and spatial data effectively is fundamental to accurately identifying spatial domains in spatial transcriptomics analysis. However, many existing methods have not yet fully exploited the local neighborhood details within spatial information. To address this issue, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541573/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Approaching a therapeutic inflection point for FLT3-mutated AML</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541573-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Combining FLT3 inhibitors with intensive chemotherapy and transplant has substantially improved AML outcomes, prompting a recent re-evaluation of FLT3-ITD&rsquo;s historically negative prognostic effect. Treatment approaches may soon undergo major changes as emerging data suggest maximal intensity does not benefit all patients and MRD potentially can guide several treatment choices. Finally, recent data also suggest FLT3 inhibitors could transform outcomes in patients unsuitable for intensive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541574/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541574-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Arterial and venous thromboses are the most significant complications in patients with myeloproliferative neoplasms (MPN), with the primary treatment goal being thrombotic risk reduction. In MPN with no history of thrombosis, primary prevention mainly involves the use of aspirin and cytoreduction is added in high-risk patients. However, thrombotic complications can unveil an MPN in approximately 20% of cases, necessitating the initiation of both antithrombotic therapy for the thrombosis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541576/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Imetelstat: A new addition to the Therapeutic Landscape of Lower-Risk MDS</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541576-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Anemia is the most prevalent cytopenia in lower-risk myelodysplastic neoplasms (LR-MDS). There is a paucity of drugs for red blood cell transfusion dependence (RBC-TD) and erythropoiesis-stimulating agents (ESAs) are the mainstay of therapy in many centers. Imetelstat, an oligonucleotide telomerase inhibitor, was recently approved for RBC-TD LR-MDS adults who are ineligible or failed prior ESA therapy. While not yet approved worldwide, here, we spotlight the current data for imetelstat and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541577/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541577-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the relapsed/refractory setting have the potential to improve outcomes and change the treatment algorithm in FL. This review focuses on the role of chimeric antigen receptor T-cells and bispecific antibodies in FL, paying special attention to sequencing approaches and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39541586/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241115181608&amp;v=2.18.0.post9&#43;e462414">Ferroptosis regulates hemolysis in stored murine and human red blood cells</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39541586-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241115181608-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Red blood cell (RBC) metabolism regulates hemolysis during aging in vivo and in the blood bank. However, the genetic underpinnings of RBC metabolic heterogeneity and extravascular hemolysis at population scale are incompletely understood. Based on the breeding of 8 founder strains with extreme genetic diversity, the Jackson laboratory diversity outbred population can capture the impact of genetic heterogeneity in like fashion to population-based studies. RBCs from 350 outbred mice, either &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39542070/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241115181459&amp;v=2.18.0.post9&#43;e462414">SpaInGNN: Enhanced clustering and integration of spatial transcriptomics based on refined graph neural networks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39542070-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241115181459-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recent developments in spatial transcriptomics (ST) technology have markedly enhanced the proposed capacity to comprehensively characterize gene expression patterns within tissue microenvironments while crucially preserving spatial context. However, the identification of spatial domains at the single-cell level remains a significant challenge in elucidating biological processes. To address this, SpaInGNN was developed, a sophisticated graph neural network (GNN) framework that &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0dVif7KL">昨天看到Trump提名Pete Hegseth任国防部部长，我当时第一反应是F**K，今天看到他提名Matt Gaetz当AG，我觉得，好吧，他其实也没想实现他说的那些“计划”。如果...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0dvif7kl/">
    
    
    
    
    
      
    
    昨天看到Trump提名Pete Hegseth任国防部部长，我当时第一反应是F**K，今天看到他提名Matt Gaetz当AG，我觉得，好吧，他其实也没想实现他说的那些“计划”。如果他真想兑现他说的去镇压反对者，他不会选Matt Gaetz。这让我想起了Succession S4E2 Logan Roy那句经典名言：You are not serious people！<!-- raw HTML omitted --><!-- raw HTML omitted -->有趣的是，今天参议院GOP没有选他的忠实随从Rick Scott，而是选了建制派John Thune当Majority Leader（多数派领袖），这实际上是Mitch McConnell首选的，这其实和历次一样，大选前团结，大选后立刻各自为政，这一结果让今后的内阁任命将变得艰难。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0f8v5XU0">晚上到Genentech（基因泰克）参加活动。Genentech是全世界第一个biotech（生物技术）公司，也是湾区最大biopharma（生物制药）公司。今天认识了附近公司的同行，...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0f8v5xu0/">
    
    
    
    
    
      
    
    晚上到Genentech（基因泰克）参加活动。Genentech是全世界第一个biotech（生物技术）公司，也是湾区最大biopharma（生物制药）公司。今天认识了附近公司的同行，包括Genentech和BioMarin科学家，UCSF和Kaiser的医生，安永的投资人，还有各种创业者。讨论最多的两个词：ADC和AI。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·South San Francisco<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/4a994b1dgy">https://tvax4.sinaimg.cn/large/4a994b1dgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/P0m8DlrQm">RFK Jr被提名为美国卫生部部长了（网页链接）。正在吃饭时，在DC的朋友给我发短信告诉我这个消息，我还以为是个笑话（parody），没想到是真的。我觉得即使GOP se...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-p0m8dlrqm/">
    
    
    
    
    
      
    
    RFK Jr被提名为美国卫生部部长了（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）。正在吃饭时，在DC的朋友给我发短信告诉我这个消息，我还以为是个笑话（parody），没想到是真的。我觉得即使GOP senators也不会任命他的。 <!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0gIqCEVP">久保史绪里 via.坂井真纪官推 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0giqcevp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.坂井真纪官推 <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0gNOgzf3">久保史绪里 『誰よりもつよく抱きしめて（紧紧拥抱）』剧照 [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0gnogzf3/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->『誰よりもつよく抱きしめて（紧紧拥抱）』剧照 <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/0">https://tvax4.sinaimg.cn/large/0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jOmootf">久保史绪里 被未来的我暴击 剧照 [图片][图片][图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jomootf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> 被未来的我暴击 剧照 <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hvm7gh1mbej31hc0">https://tvax4.sinaimg.cn/large/006z6nxLgy1hvm7gh1mbej31hc0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jQExknG">久保史绪里#shiorigram# 非常棒的照片。。☺️ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jqexkng/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->非常棒的照片。。☺️ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jQuBaWS">久保史绪里#shiorigram# 今晚10:45～（JST）被未来的我暴击！？暴击第六周在今天也到最后了。昨天是非常温暖的一集呢。今晚会怎么样呢。。只剩下两周了，请一定...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jqubaws/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/P0jRccrFo">久保史绪里 via.nhk_dramas [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-p0jrccrfo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --> via.nhk_dramas <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hvm7oj88jcj30qo">https://tvax2.sinaimg.cn/large/006z6nxLgy1hvm7oj88jcj30qo</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/11/14/1212866785/throughline-behind-the-scenes">Behind the Scenes of Throughline</a></h1>
  <div class="date-author">
    
    <span class="date">2024-11-14</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-11-14-1212866785-throughline-behind-the-scenes/">
    
    
    
    
    
      
    
    Today on the show, we&rsquo;re taking you behind the scenes. We&rsquo;ll tell you how Throughline was born, some of what goes into making our episodes, and a little bit about how we make our special sauce — the Throughline <!-- raw HTML omitted -->rizz, <!-- raw HTML omitted -->as the kids say.<!-- raw HTML omitted --><!-- raw HTML omitted -->If you want more of these behind-the-scenes conversations become a Throughline+ subscriber. You can find out more at plus.npr.org/throughline.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices.com/adchoices<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

